| 26.2.60
|
CVA Reading 1, p.37, pl.23, no.2a-b; Lemos 1991 p.303, no.1113, pl.153; Villing et al 2013-2015 (ORC) GD.0866 phase 2;
|
|
| 26.2.61
|
CVA Reading 1, p.37, pl.23, no.3a-b; Villing et al 2013-2015 (ORC) GD.1522 phase 2; Lemos 1991 p.303, no.1115, pl.153;
|
|
| 26.2.65
|
CVA Reading 1,p.37, pl.23, no.7a-b; Lemos 1991 p.303, no. 1116, pl.153; Villing et al 2013-2015 (ORC) GD.1521 phase 2;
|
|
| 26.2.69
|
CVA Reading 1,p.38, pl. 23., no,11a-b; Lemos 1991 p.303, no.1117, pl.153; Villing et al 2013-2015 (ORC) GD.1215 phase 2;
|
|